Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jupiter Neurosciences (JUNS) Net Cash Flow (2024 - 2025)

Jupiter Neurosciences (JUNS) has disclosed Net Cash Flow for 2 consecutive years, with -$2.4 million as the latest value for Q4 2025.

  • Quarterly Net Cash Flow fell 162.82% to -$2.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$5.4 million through Dec 2025, down 244.71% year-over-year, with the annual reading at $19832.0 for FY2025, 99.47% down from the prior year.
  • Net Cash Flow for Q4 2025 was -$2.4 million at Jupiter Neurosciences, down from -$1.2 million in the prior quarter.
  • The five-year high for Net Cash Flow was $3.8 million in Q4 2024, with the low at -$2.4 million in Q4 2025.